Verve Therapeutics, Inc. (VERV) Insider Trading -- Recent Executive & Director Transactions

18 insiders reported 54 Form 4 transactions for Verve Therapeutics, Inc. (VERV) over the past 18 months (most recent 2025-07-28). Recent activity: GV 2017 GP, L.P. (Insider) Sell 4.3M shares, GV 2017 GP, L.L.C. (Insider) Sell 6.1M shares, Kathiresan Sekar (Chief Executive Officer) Sell 240,997 shares, Lister Troy (Chief Scientific Officer) Sell 6,952 shares, Nickerson Joan (Chief Administrative Officer) Sell 17,420 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2025-07-28GV 2017 GP, L.P.InsiderSell4.3M$0
2025-07-28GV 2017 GP, L.L.C.InsiderSell6.1M$0
2025-07-28Kathiresan SekarChief Executive OfficerSell240,997$0
2025-07-28Lister TroyChief Scientific OfficerSell6,952$0
2025-07-28Nickerson JoanChief Administrative OfficerSell17,420$0
2025-07-28Dorval AllisonChief Financial OfficerSell13,280$0
2025-07-28Yeshwant KrishnaDirectorSell6.1M$0
2025-07-28GV 2019 GP, L.L.C.InsiderSell4.3M$0
2025-07-28Yeshwant KrishnaDirectorSell1.8M$0
2025-07-28ADELMAN BURT ADirectorSell428,326$0
2025-07-28Ashe Andrew D.See RemarksSell348,828$0
2025-07-28GV 2023, L.P.InsiderSell6.1M$0
2025-07-28GV 2017 GP, L.P.InsiderSell6.1M$0
2025-07-28GV 2017, L.P.InsiderSell6.1M$0
2025-07-28GV 2023 GP, L.L.C.InsiderSell6.1M$0
2025-07-28GV 2019 GP, L.L.C.InsiderSell6.1M$0
2025-07-28GV 2019 GP, L.P.InsiderSell6.1M$0
2025-07-28GV 2023 GP, L.P.InsiderSell6.1M$0
2025-07-28GV 2019, L.P.InsiderSell6.1M$0
2025-07-28Kathiresan SekarChief Executive OfficerSell110,997$0
2025-07-28Alphabet Inc.InsiderSell6.1M$0
2025-07-28Kathiresan SekarChief Executive OfficerSell348,431$0
2025-07-28GV 2023 GP, L.L.C.InsiderSell4.3M$0
2025-07-28GV 2017, L.P.InsiderSell4.3M$0
2025-07-28Yeshwant KrishnaDirectorSell4.3M$0

Source: SEC Form 4 filings · as of 2025-07-28